Cyclophosphamid (German Wikipedia)

Analysis of information sources in references of the Wikipedia article "Cyclophosphamid" in German language version.

refsWebsite

Global rank German rank

4^th place

7^th place

2^nd place

3^rd place

813^th place

69^th place

5,401^st place

312^th place

low place

awmf.org

S1-Leitlinie Medulloblastom im Kindes- und Jugendalter der Gesellschaft für Pädiatrische Onkologie und Hämatologie (GPOH). In: AWMF online (Stand 11/2012)

Eintrag zu Cyclophosphamid in der GESTIS-Stoffdatenbank des IFA, abgerufen am 20. Januar 2022. (JavaScript erforderlich)

C. Krishnan, A. I. Kaplin u. a.: Reduction of disease activity and disability with high-dose cyclophosphamide in patients with aggressive multiple sclerosis. In: Archives of neurology. Band 65, Nummer 8, August 2008, S. 1044–1051, doi:10.1001/archneurol.65.8.noc80042, PMID 18541787, PMC 2574697 (freier Volltext).
D. M. Harrison, D. E. Gladstone u. a.: Treatment of relapsing-remitting multiple sclerosis with high-dose cyclophosphamide induction followed by glatiramer acetate maintenance. In: Multiple sclerosis. Band 18, Nummer 2, Februar 2012, S. 202–209, doi:10.1177/1352458511419701, PMID 21865410, PMC 3612927 (freier Volltext).
P. A. Monach, L. M. Arnold, P. A. Merkel: Incidence and prevention of bladder toxicity from cyclophosphamide in the treatment of rheumatic diseases: a data-driven review. In: Arthritis and rheumatism. Band 62, Nummer 1, Januar 2010, S. 9–21, doi:10.1002/art.25061, PMID 20039416 (Review).

T. K. Chang, G. F. Weber u. a.: Differential activation of cyclophosphamide and ifosphamide by cytochromes P-450 2B and 3A in human liver microsomes. In: Cancer Research. Band 53, Nummer 23, Dezember 1993, S. 5629–5637, PMID 8242617.
C. Krishnan, A. I. Kaplin u. a.: Reduction of disease activity and disability with high-dose cyclophosphamide in patients with aggressive multiple sclerosis. In: Archives of neurology. Band 65, Nummer 8, August 2008, S. 1044–1051, doi:10.1001/archneurol.65.8.noc80042, PMID 18541787, PMC 2574697 (freier Volltext).
D. M. Harrison, D. E. Gladstone u. a.: Treatment of relapsing-remitting multiple sclerosis with high-dose cyclophosphamide induction followed by glatiramer acetate maintenance. In: Multiple sclerosis. Band 18, Nummer 2, Februar 2012, S. 202–209, doi:10.1177/1352458511419701, PMID 21865410, PMC 3612927 (freier Volltext).
P. A. Monach, L. M. Arnold, P. A. Merkel: Incidence and prevention of bladder toxicity from cyclophosphamide in the treatment of rheumatic diseases: a data-driven review. In: Arthritis and rheumatism. Band 62, Nummer 1, Januar 2010, S. 9–21, doi:10.1002/art.25061, PMID 20039416 (Review).
R. Ader, N. Cohen: Behaviorally conditioned immunosuppression. In: Psychosomatic medicine. Band 37, Nummer 4, 1975, S. 333–340, PMID 1162023.

R. Ader, N. Cohen: Behaviorally conditioned immunosuppression. In: Psychosomatic medicine. Band 37, Nummer 4, 1975, S. 333–340, PMID 1162023.